Medical News Update
- What's New Related to Drugs
- Sexual Enhancement and Energy Product Notifications
- 10 Day Forecast may be harmful due to hidden ingredients
- GDUFA Paid Facilities List
- Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations - 10/14/2026
- CDER Small Business & Industry Assistance (SBIA)
- FDA Rare Disease Framework Initiative Public Meeting - 10/28/2026
- Advancing Generic Drug Development: Leveraging Model-Integrated Evidence (MIE) in the Development & Approval of Generic Drugs - 08/27/2026
- Advancing Generic Drug Development: Modernizing Bioequivalence Approaches for Topical & Transdermal Products - 09/10/2026
- FDA Rare Disease Innovation Hub
- Drug Alerts and Statements
- Rare Disease Framework
- FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development
- FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
- Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
- Oncology (Cancer)/Hematologic Malignancies Approval Notifications
- FDA approves an expanded indication for nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
- Recently Issued Guidance Documents
- Drugs@FDA Data Files
- Help More Providers Prescribe with Confidence